Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 251-260 of 560 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Long-Term Follow-up Protocol For Participants Treated With Gene-Modified T Cells

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study Of Elotuzumab, Daratumumab, Iberdomide, And Dexamethasone For Relapsed Multiple Myeloma

    Rochester, MN

  3. Quizartinib Or Placebo Plus Chemotherapy In Newly Diagnosed Patients With FLT3-ITD Negative AML

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study for Cerebral Open Flow Microperfusion

    Rochester, MN

  5. Actinium Therapy For Late-stage Aggressive Sarcomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Testing The Addition Of An Anti-Cancer Drug, Gemcitabine, To Usual Treatment (BCG Alone) In People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)

    Jacksonville, FL

  8. Phase 3 Study Of Taletrectinib Vs Placebo As An Adjuvant Therapy In ROS1 Positive NSCLC (TRUST-IV)

    Rochester, MN

  9. SIGMA (Safusidenib In IDH1 Mutant Glioma Maintenance)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. I-SPY TRIAL: Neoadjuvant And Personalized Adaptive Novel Agents To Treat Breast Cancer (I-SPY)

    Rochester, MN

.

Mayo Clinic Footer